nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Tramadol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Tramadol—Myocardial infarction—Prednisone—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Tramadol—Breast disorder—Methotrexate—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Tramadol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Tramadol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Tramadol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Tramadol—Insomnia—Lisinopril—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Tramadol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000288	CcSEcCtD
Tramadol—Paraesthesia—Lisinopril—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Tramadol—Vomiting—Captopril—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Tramadol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Tramadol—Dyspnoea—Lisinopril—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Tramadol—Rash—Captopril—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Tramadol—Dermatitis—Captopril—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Tramadol—Somnolence—Lisinopril—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Tramadol—Headache—Captopril—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Tramadol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000282	0.000282	CcSEcCtD
Tramadol—Dyspepsia—Lisinopril—systemic scleroderma	0.000281	0.000281	CcSEcCtD
Tramadol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Tramadol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Tramadol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Tramadol—Asthma—Methotrexate—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Tramadol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Tramadol—Decreased appetite—Lisinopril—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Tramadol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Tramadol—Fatigue—Lisinopril—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Tramadol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Tramadol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Tramadol—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Tramadol—Hypersensitivity—Leflunomide—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Tramadol—Pancreatitis—Methotrexate—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Tramadol—Pain—Lisinopril—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Tramadol—Constipation—Lisinopril—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Tramadol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Tramadol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Tramadol—Bradycardia—Prednisone—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Tramadol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Tramadol—Diarrhoea—Azathioprine—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Tramadol—Haemoglobin—Prednisone—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Tramadol—Nausea—Captopril—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Tramadol—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Tramadol—Haemorrhage—Prednisone—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Tramadol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Tramadol—Asthenia—Leflunomide—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Tramadol—Hallucination—Prednisone—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Tramadol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Tramadol—Pruritus—Leflunomide—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Tramadol—Connective tissue disorder—Prednisone—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Tramadol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Tramadol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Tramadol—Dysuria—Methotrexate—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Tramadol—Dizziness—Azathioprine—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Tramadol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Tramadol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000255	CcSEcCtD
Tramadol—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000255	0.000255	CcSEcCtD
Tramadol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Tramadol—Diarrhoea—Leflunomide—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Tramadol—Urticaria—Lisinopril—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Tramadol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Tramadol—Abdominal pain—Lisinopril—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Tramadol—Body temperature increased—Lisinopril—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Tramadol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Tramadol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Tramadol—Vomiting—Azathioprine—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Tramadol—Pneumonia—Methotrexate—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Tramadol—Eye disorder—Prednisone—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Tramadol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Tramadol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Tramadol—Infestation NOS—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Tramadol—Infestation—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Tramadol—Rash—Azathioprine—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Tramadol—Dermatitis—Azathioprine—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Tramadol—Depression—Methotrexate—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Tramadol—Flushing—Prednisone—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Tramadol—Headache—Azathioprine—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000246	0.000246	CcSEcCtD
Tramadol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000246	CcSEcCtD
Tramadol—Dizziness—Leflunomide—systemic scleroderma	0.000246	0.000246	CcSEcCtD
Tramadol—Renal failure—Methotrexate—systemic scleroderma	0.000244	0.000244	CcSEcCtD
Tramadol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Tramadol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Tramadol—Stomatitis—Methotrexate—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Tramadol—Angiopathy—Prednisone—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Tramadol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Tramadol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Tramadol—Immune system disorder—Prednisone—systemic scleroderma	0.000241	0.000241	CcSEcCtD
Tramadol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000239	CcSEcCtD
Tramadol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000239	CcSEcCtD
Tramadol—Arrhythmia—Prednisone—systemic scleroderma	0.000239	0.000239	CcSEcCtD
Tramadol—Sweating—Methotrexate—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Tramadol—Haematuria—Methotrexate—systemic scleroderma	0.000237	0.000237	CcSEcCtD
Tramadol—Vomiting—Leflunomide—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Tramadol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Tramadol—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Tramadol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Tramadol—Epistaxis—Methotrexate—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Tramadol—Rash—Leflunomide—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Tramadol—Dermatitis—Leflunomide—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Tramadol—Mental disorder—Prednisone—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Tramadol—Nausea—Azathioprine—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Tramadol—Headache—Leflunomide—systemic scleroderma	0.000233	0.000233	CcSEcCtD
Tramadol—Erythema—Prednisone—systemic scleroderma	0.000232	0.000232	CcSEcCtD
Tramadol—Malnutrition—Prednisone—systemic scleroderma	0.000232	0.000232	CcSEcCtD
Tramadol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Tramadol—Asthenia—Lisinopril—systemic scleroderma	0.000229	0.000229	CcSEcCtD
Tramadol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000229	CcSEcCtD
Tramadol—Pruritus—Lisinopril—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Tramadol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Tramadol—Haemoglobin—Methotrexate—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Tramadol—Rash—Mycophenolic acid—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Tramadol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Tramadol—Haemorrhage—Methotrexate—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Tramadol—Hepatitis—Methotrexate—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Tramadol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000222	CcSEcCtD
Tramadol—Headache—Mycophenolic acid—systemic scleroderma	0.000222	0.000222	CcSEcCtD
Tramadol—Pharyngitis—Methotrexate—systemic scleroderma	0.000222	0.000222	CcSEcCtD
Tramadol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Tramadol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Tramadol—Nausea—Leflunomide—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Tramadol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Tramadol—Vision blurred—Prednisone—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Tramadol—Urethral disorder—Methotrexate—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Tramadol—Diarrhoea—Lisinopril—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Tramadol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Tramadol—Visual impairment—Methotrexate—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Tramadol—Anaemia—Prednisone—systemic scleroderma	0.000215	0.000215	CcSEcCtD
Tramadol—Agitation—Prednisone—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Tramadol—Angioedema—Prednisone—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Tramadol—Dizziness—Lisinopril—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Tramadol—Erythema multiforme—Methotrexate—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Tramadol—Nausea—Mycophenolic acid—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Tramadol—Malaise—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Tramadol—Vertigo—Prednisone—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Tramadol—Eye disorder—Methotrexate—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Tramadol—Syncope—Prednisone—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Tramadol—Tinnitus—Methotrexate—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Tramadol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000207	0.000207	CcSEcCtD
Tramadol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Tramadol—Loss of consciousness—Prednisone—systemic scleroderma	0.000204	0.000204	CcSEcCtD
Tramadol—Vomiting—Lisinopril—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—systemic scleroderma	0.000202	0.000202	CcSEcCtD
Tramadol—Rash—Lisinopril—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Tramadol—Convulsion—Prednisone—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Tramadol—Dermatitis—Lisinopril—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Tramadol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Tramadol—Hypertension—Prednisone—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Tramadol—Chills—Methotrexate—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Tramadol—Headache—Lisinopril—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Tramadol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Tramadol—Arthralgia—Prednisone—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Tramadol—Myalgia—Prednisone—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Tramadol—Anxiety—Prednisone—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Tramadol—Discomfort—Prednisone—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Tramadol—Erythema—Methotrexate—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Tramadol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000192	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Tramadol—Nausea—Lisinopril—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Tramadol—Anaphylactic shock—Prednisone—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Tramadol—Infection—Prednisone—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Tramadol—Back pain—Methotrexate—systemic scleroderma	0.000188	0.000188	CcSEcCtD
Tramadol—Shock—Prednisone—systemic scleroderma	0.000187	0.000187	CcSEcCtD
Tramadol—Nervous system disorder—Prednisone—systemic scleroderma	0.000186	0.000186	CcSEcCtD
Tramadol—Tachycardia—Prednisone—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Tramadol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Tramadol—Skin disorder—Prednisone—systemic scleroderma	0.000184	0.000184	CcSEcCtD
Tramadol—Hyperhidrosis—Prednisone—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Tramadol—Anorexia—Prednisone—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00018	0.00018	CcSEcCtD
Tramadol—Anaemia—Methotrexate—systemic scleroderma	0.00018	0.00018	CcSEcCtD
Tramadol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000178	CcSEcCtD
Tramadol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Tramadol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Tramadol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Tramadol—Malaise—Methotrexate—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Tramadol—Vertigo—Methotrexate—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Tramadol—Insomnia—Prednisone—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Tramadol—Paraesthesia—Prednisone—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Tramadol—Cough—Methotrexate—systemic scleroderma	0.00017	0.00017	CcSEcCtD
Tramadol—Convulsion—Methotrexate—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Tramadol—Dyspepsia—Prednisone—systemic scleroderma	0.000167	0.000167	CcSEcCtD
Tramadol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Tramadol—Chest pain—Methotrexate—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Tramadol—Myalgia—Methotrexate—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Tramadol—Decreased appetite—Prednisone—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Tramadol—Fatigue—Prednisone—systemic scleroderma	0.000164	0.000164	CcSEcCtD
Tramadol—Discomfort—Methotrexate—systemic scleroderma	0.000163	0.000163	CcSEcCtD
Tramadol—Constipation—Prednisone—systemic scleroderma	0.000162	0.000162	CcSEcCtD
Tramadol—Confusional state—Methotrexate—systemic scleroderma	0.00016	0.00016	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Tramadol—Infection—Methotrexate—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Tramadol—Feeling abnormal—Prednisone—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Tramadol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000155	0.000155	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—systemic scleroderma	0.000154	0.000154	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Tramadol—Anorexia—Methotrexate—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Tramadol—Urticaria—Prednisone—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Tramadol—Body temperature increased—Prednisone—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Tramadol—Abdominal pain—Prednisone—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Tramadol—Hypotension—Methotrexate—systemic scleroderma	0.000148	0.000148	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000144	0.000144	CcSEcCtD
Tramadol—Insomnia—Methotrexate—systemic scleroderma	0.000143	0.000143	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—systemic scleroderma	0.000142	0.000142	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—systemic scleroderma	0.000141	0.000141	CcSEcCtD
Tramadol—Somnolence—Methotrexate—systemic scleroderma	0.000141	0.000141	CcSEcCtD
Tramadol—Hypersensitivity—Prednisone—systemic scleroderma	0.00014	0.00014	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—systemic scleroderma	0.00014	0.00014	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—systemic scleroderma	0.000138	0.000138	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000137	0.000137	CcSEcCtD
Tramadol—Fatigue—Methotrexate—systemic scleroderma	0.000137	0.000137	CcSEcCtD
Tramadol—Asthenia—Prednisone—systemic scleroderma	0.000136	0.000136	CcSEcCtD
Tramadol—Pain—Methotrexate—systemic scleroderma	0.000136	0.000136	CcSEcCtD
Tramadol—Pruritus—Prednisone—systemic scleroderma	0.000134	0.000134	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000131	0.000131	CcSEcCtD
Tramadol—Diarrhoea—Prednisone—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Tramadol—Urticaria—Methotrexate—systemic scleroderma	0.000126	0.000126	CcSEcCtD
Tramadol—Dizziness—Prednisone—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Tramadol—Vomiting—Prednisone—systemic scleroderma	0.000121	0.000121	CcSEcCtD
Tramadol—Rash—Prednisone—systemic scleroderma	0.00012	0.00012	CcSEcCtD
Tramadol—Dermatitis—Prednisone—systemic scleroderma	0.00012	0.00012	CcSEcCtD
Tramadol—Headache—Prednisone—systemic scleroderma	0.000119	0.000119	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000117	0.000117	CcSEcCtD
Tramadol—Asthenia—Methotrexate—systemic scleroderma	0.000114	0.000114	CcSEcCtD
Tramadol—Nausea—Prednisone—systemic scleroderma	0.000113	0.000113	CcSEcCtD
Tramadol—Pruritus—Methotrexate—systemic scleroderma	0.000112	0.000112	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—systemic scleroderma	0.000108	0.000108	CcSEcCtD
Tramadol—Dizziness—Methotrexate—systemic scleroderma	0.000105	0.000105	CcSEcCtD
Tramadol—Vomiting—Methotrexate—systemic scleroderma	0.000101	0.000101	CcSEcCtD
Tramadol—Rash—Methotrexate—systemic scleroderma	0.0001	0.0001	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—systemic scleroderma	9.99e-05	9.99e-05	CcSEcCtD
Tramadol—Headache—Methotrexate—systemic scleroderma	9.93e-05	9.93e-05	CcSEcCtD
Tramadol—Nausea—Methotrexate—systemic scleroderma	9.42e-05	9.42e-05	CcSEcCtD
